Maja Hellfritzsch

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Oral Anticoagulants

Tyrosine Kinase

Top Venues

Basic & clinical pharmacology & toxicology

Annals of internal medicine

European journal of clinical pharmacology

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Elise Engell, Andreas Ludvig Ohm Svendsen, Bent Struer Lind, Tore Bjerregaard Stage, Maja Hellfritzsch, Jesper Hallas
Drug-drug interactions between vitamin K antagonists and statins: a systematic review. European journal of clinical pharmacology 77 (10) (2021)
Maja Hellfritzsch, Jakob Christensen, Lars Peter Nielsen
Rivaroxaban Plasma Levels and Levetiracetam. Annals of internal medicine 173 (9) (2020)
Maja Hellfritzsch, Anton Pottegård, Simone Bonde Haastrup, Lotte Rasmussen, Erik Lerkevang Grove
Cohort selection in register-based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade-off between selection bias and misclassification. Basic & clinical pharmacology & toxicology 127 (1) (2020)
David Gaist, Luis Alberto García Rodríguez, Stine Munk Hald, Maja Hellfritzsch, Frantz R Poulsen, Bo Halle, Jesper Hallas, Jesper Hallas
Antidepressant drug use and subdural hematoma risk. Journal of thrombosis and haemostasis : JTH 18 (2) (2019)
Anne Mette Dybro, Per Damkier, Torsten Bloch Rasmussen, Maja Hellfritzsch
Statin-associated rhabdomyolysis triggered by drug-drug interaction with itraconazole. BMJ case reports 2016 (2016)